Alfred D. Kingsley - Jun 23, 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Role: Director
Signature: /s/ Alfred D. Kingsley
Stock symbol: OCX
Transactions as of: Jun 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/27/2023, 09:30 PM
Previous filing: Jun 15, 2023
Next filing: Jul 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCX	Common Stock, no par value	Award	$0	+20K	+4.26%	$0.00	489K	Jun 23, 2023	Direct	F1
holding	OCX	Common Stock, no par value						75.3K	Jun 23, 2023	See Footnote	F2
holding	OCX	Common Stock, no par value						18.8K	Jun 23, 2023	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCX	Option to Purchase Common Stock	Award	$0	+90K		$0.00	90K	Jun 23, 2023	Common Stock	90K	$0.20	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
F2	The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.
F3	The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.
F4	Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.